+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications



Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications



Acta Obstetricia et Gynecologica Scandinavica 77(2): 165-169



Background. Disseminated intravascular coagulation (DIC) is a frequently observed complication in pregnant women. The laboratory diagnosis of DIC is difficult but the development in the detection of circulating soluble fibrin has improved the possibility. Methods. A number of pregnant women (n = 175) with obstetric complications e.g. preeclampsia, hypertension, intrauterine growth retardation (IUGR) and intrahepatic cholestasis was examined for plasma soluble fibrin and subjected to some routine hemostatic tests, mainly during the third trimester of pregnancy. Results. Of these patients, 57 of 175 (33%) had an elevated concentration of soluble fibrin (above 23 nmol/L) as compared with a healthy group of women sampled in the third trimester. Eighteen patients (10%) had highly increased levels, above 100 nmol/L. In comparison, none of the 23 healthy, pregnant women investigated had a value above 40 nmol/L. Conclusions. Hemostatic abnormalities, including increased concentrations of soluble fibrin, are quite frequently observed in women with obstetric complications, most likely as a sign of a systemic activation of coagulation. Although a higher concentration of plasma soluble fibrin was observed in many of the women, no clear correlation to the outcome of the pregnancy was obtained. Whether or not plasma soluble fibrin is of any value, either diagnostically or the treatment of patients with pregnancy complications, remains to be shown.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009431972

Download citation: RISBibTeXText

PMID: 9512320

DOI: 10.1034/j.1600-0412.1998.770206.x


Related references

Characterization of soluble fibrin in plasma samples of patients with intravascular coagulation with fibrin-specific monoclonal antibodies and detection of DesA-fibrin monomer. Fibrinolysis 10(SUPPL 4): 14, 1996

Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation. Rinsho Byori. Japanese Journal of Clinical Pathology 49(8): 813-817, 2001

Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation. Clinical and Applied Thrombosis/Hemostasis 9(3): 233-240, 2003

Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis 5(5): 725-730, 1994

Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. American Journal of Hematology 51(4): 255-260, 1996

Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. American Journal of Hematology 51(3): 186-191, 1996

Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis. Blood Coagulation & Fibrinolysis 24(2): 150-156, 2013

Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Seminars in Thrombosis and Hemostasis 27(6): 657-666, 2001

A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma. Clinica Chimica Acta 318(1-2): 25-32, April, 2002

Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. Blood Coagulation & Fibrinolysis 13(4): 301-308, 2002

Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis. Haematologica 90(3): 419-421, 2005

Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma. Thrombosis et Diathesis Haemorrhagica 30(2): 403-413, 1973

Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage. Japanese Journal of Medical Science & Biology 30(2): 91-99, 1977

Plasma fibrinogen levels and soluble fibrin monomer complexes in diabetes mellitus and its complications. Indian Journal of Nutrition and Dietetics 42(6): 279-285, 2005

Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen. Thrombosis and Haemostasis 54(2): 533-538, 1985